Dorzolamide Hydrochloride/Timolol Maleate

盐酸多佐胺/马来酸噻吗洛尔

Report date: 2023/08/04 18:05:00

Base Information

Drug NameDorzolamide Hydrochloride/Timolol Maleate
Drug Alias NameTimolol Maleate and Dorzolamide Hydrochloride马来酸噻吗洛尔/盐酸多佐胺盐酸多佐胺马来酸噻吗洛尔Dorzolamide hydrochloride - timolol maleate mixtDorzolamide/timolol +[9] 
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors antagonistsCarbonic anhydrases inhibitors
TargetsCarbonic anhydrasesBeta adrenergic receptors
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved Date1998/02/10
Country/TerritoryUnited StatesMexicoMainland China +[4] 
CombinationsYes Dorzolamide HydrochlorideTimolol Maleate
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesThea Pharma IncLaboratoires Thea SASSanten
Inactive CompaniesMerck Sharp & Dohme (China) LtdMerck Sharp & Dohme LLCMerck Sharp & Dohme (China) Co Ltd
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01ED51
Related LinksWikipediaKEGG